Communicating genetics research results to families: Problems arising when the patient participant is deceased

Psycho-Oncology

Volumn 17, Issue 8, 2008, Pages 804-811

  Ormondroyd, E ^a   Moynihan, C ^a   Ardem Jones, A ^b   Eeles, R ^a,b   Foster, C ^c   Davolls, S ^a   Watson, Maggie ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cancer genetics; Deceased relative; Family communication; Oncology; Qualitative

Indexed keywords

BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; EXPLORATORY RESEARCH; FAMILY COUNSELING; FAMILY RELATION; FEMALE; GENETIC SERVICE; HIGH RISK POPULATION; HUMAN; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; MALE; MUTATIONAL ANALYSIS; PHENOMENOLOGY; QUALITATIVE RESEARCH; RELATIVE; SPOUSE;

BIOMEDICAL RESEARCH; BREAST NEOPLASMS; COMMUNICATION; CROSS-SECTIONAL STUDIES; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETICS; HUMANS; INFORMATION DISSEMINATION; PROFESSIONAL-FAMILY RELATIONS;

EID: 51649083836     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1356     Document Type: Article

References (40)

1. Foster C, Evans DG, Eeles R et al. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 2002;86(8):1209-1216.
2. Brooks L, Lennard F, Shenton A et al. BRCA1/2 predictive testing: a study of uptake in two centres. Eur J Hum Genet 2004; 12(8):654-662.
3. General Medical Council. Confidentiality: Protecting and Providing Information. 2006. http://www.gmc-uk.org/guidance. Accessed 15 March 2008.
4. Patterson AR, Robinson LD, Naftalis EZ, Haley BB, Tomlinson GE. Custodianship of genetic information: clinical challenges and professional responsibility. J Clin Oncol 2005; 23(9):2100-2104.
5. Claes E, Evers-Kiebooms G, Boogaerts A et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 2003;116(1):11-19.
6. Hughes C, Lerman C, Schwartz M et al. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002; 107(2): 143-150.
7. Foster C, Eeles R, Ardern-Jones A, Moynihan C, Watson M. Juggling roles and expectations: dilemmas faced by women talking to relatives about cancer and genetic testing. Psychol Health 2004; 19(4):439-455.
8. McGivern B, Everett J, Yager GG, Baumiller RC, Hafertepen A, Saal HM. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 2004;6(6):503-509.
9. Mesters I, Ausems M, Eichhorn S, Vasen H. Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 2005; 4(2):163-167.
10. Green J, Richards M, Murton F, Statham H, Hallowell N. Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns 1997;6(1):45-60.
11. Forrest K, Simpson SA, Wilson BJ et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003;64(4):317-326.
12. Foster C, Watson M, Moynihan C, Ardern-Jones A, Eeles R. Genetic testing for cancer predisposition: cancer burden and responsibility. J Health Psychol 2002;7(4):469-484.
13. Gaff CL, Collins V, Symes T, Halliday J. Facilitating family communication about predictive genetic testing: probands' perceptions. J Genet Couns 2005;14(2): 133-140.
14. d'Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001;15(3):231-247.
15. Hallowell N, Foster C, Eeles R et al. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics 2003; 29(2):74-79.
16. Ormond KE, Mills PL, Lester LA, Ross LF. Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet C Semin Med Genet 2003;119(1):70-77.
17. Julian-Reynier C, Eisinger F, Chabal F et al. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors. Am J Med Genet 2000; 94(1):13-18.
18. Wagner Costalas J, Itzen M, Malick J et al. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet C Semin Med Genet 2003; 119(1):11-18.
19. Sermijn E, Goelen G, Teugels E et al. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 2004; 41(3):e23-30.
20. Hallowell N, Ardern-Jones A, Eeles R et al. Men's decision-making about predictive BRCA1/2 testing: the role of family. J Genet Couns 2005;14(3):207-217.
21. Hallowell N, Ardern-Jones A, Eeles R et al. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet 2005; 67(6):492-502.
22. Daly PA, Nolan C, Green A et al. Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol 2003; 14(4):549-553.
23. Segal J, Esplen MJ, Toner B et al. An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. Am J Med Genet A 2004;125(3): 267-272.
24. Wilson BJ, Forrest K, van Teijlingen ER et al. Family communication about genetic risk: the little that is known. Community Genet 2004;7(1):15-24.
25. Edwards SM, Kote-Jarai Z, Meitz J et al. British Association of Urological Surgeons Section of Oncology. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003;72(1):1-12.
26. Ormondroyd E, Moynihan C, Watson M et al. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives. J Genet Couns 2007;16(4): 527-538.
27. Smith JA, Jarman M, Osborn M. Doing interpretative phenomenological analysis. In Qualitative Health Psychology: Theories and Methods, Murray M, Chamberlain K (eds). Sage: London, 1999.
28. Peterson SK, Watts BG, Koehly LM et al. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 2003;119(1):78-86.
29. Clarke A, Richards M, Kerzin-Storrar L et al. Genetic professionals' reports of nondisclosure of genetic risk information within families. Eur J Hum Genet 2005; 13(5):556-562.
30. Shalowitz DI, Miller FG. Disclosing individual results of clinical research: implications of respect for participants. J Am Med Assoc 2005;294(6):737-740.
31. Parker M, Lucassen AM. Genetic information: a joint account? Br Med J 2004;329(7458):165-167.
32. Wilcke JT. Late onset genetic disease: where ignorance is bliss, is it folly to inform relatives? Br Med J 1998;317(7160):744-747.
33. Sulmasy DP. On warning families about genetic risk: the ghost of Tarasoff. Am J Med 2000;109(9):738-739.
34. Knoppers BM. Genetic information and the family: are we our brother's keeper? Trends Biotechnol 2002;20(2): 85-86.
35. Falk MJ, Dugan RB, O'Riordan MA, Matthews AL, Robin NH. Medical geneticists' duty to warn at-risk relatives for genetic disease. Am J Med Genet A 2003; 120(3):374-380.
36. Dugan RB, Wiesner GL, Juengst ET et al. Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience. Am J Med Genet C Semin Med Genet 2003;119(1):27-34.
37. Suthers G, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006; 43(8):665-670.
38. Human Genetics Commission. Whose Hands on Your Genes. 2000. http.//www.hgc.gov.uk. Accessed 14 November 2006.
39. Newson AJ, Humphries SE. Cascade testing in familial hypercholesterolaemia: how should family members be contacted? Eur J Hum Genet 2005;13(4):401-408.
40. Nicolas P. Discussing options between patients and health care professionals in genetic diagnosis: ethical and legal criteria. Hereditary Cancer Clin Pract 2007; 5(3):144-152.